Stavros G. Vizirgianakis - 15 Jan 2025 Form 4 Insider Report for Apyx Medical Corp (APYX)

Role: Director
Signature: /s/ Stavros G. Vizirgianakis
Issuer symbol: APYX
Transactions as of: 15 Jan 2025
Transactions value $: $0
Form type: 4
Filing time: 17 Jan 2025, 16:07:01 UTC
Previous filing: 19 Aug 2024
Next filing: 12 Jun 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APYX	Stock Option (Option to Buy)	Award	$0	+50K		$0.00	50K	15 Jan 2025	Common Stock	50K	$1.42	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Issued pursuant to the Issuer's Director Compensation Program, as amended, which provides for the issuance of a stock option to non-employee directors with an exercise price equal to the closing price of the Issuer's common stock on its principal exchange on the second trading day following the Issuer's release of its preliminary 2024 revenue. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant.

Content

Issued pursuant to the Issuer's Director Compensation Program, as amended, which provides for the issuance of a stock option to non-employee directors with an exercise price equal to the closing price of the Issuer's common stock on its principal exchange on the second trading day following the Issuer's release of its preliminary 2024 revenue. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant.